Activist Investor Pushes Bio-Techne Toward Sale

Ananym Capital Management, an activist investor, has acquired a significant stake in Bio-Techne Corp. The firm is now urging the company's board of directors to initiate a comprehensive strategic review. A key outcome of this review could be the exploration of a potential sale of the biotechnology company. This move signals a push for significant changes within Bio-Techne's leadership and operational structure, potentially leading to a new ownership.